牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

维康药业（300878）

4.5

综合诊断：4.5分打败了8%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
下跌有所减缓，仍应保持谨慎。
长期趋势：
已有4家主力机构披露2025-12-31报告期持股数据，持仓量总计1.21万股，占流通A股0.01%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

4.5分

5.6分

4.9分

2.4分

4.1分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：4.5技术面打败了9%的股票技术面评分前10的股票

近期的平均成本为26.38元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为26.38元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"26.38","date":1776068506,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。

[{"date":"2026.04.14","stock":"-0.34","trade":"0.36","ind":"1.61"},{"date":"2026.04.13","stock":"-2.92","trade":"-1.82","ind":"0.69"},{"date":"2026.04.10","stock":"-0.62","trade":"0.01","ind":"2.24"},{"date":"2026.04.09","stock":"-2.47","trade":"-1.54","ind":"-0.33"},{"date":"2026.04.08","stock":"1.91","trade":"0.62","ind":"4.79"},{"date":"2026.04.07","stock":"2.78","trade":"0.87","ind":"0.36"},{"date":"2026.04.03","stock":"-3.22","trade":"-2.39","ind":"-0.99"},{"date":"2026.04.02","stock":"-0.78","trade":"0.62","ind":"-1.60"},{"date":"2026.04.01","stock":"2.29","trade":"2.36","ind":"1.70"},{"date":"2026.03.31","stock":"-1.93","trade":"-0.69","ind":"-1.81"},{"date":"2026.03.30","stock":"1.08","trade":"1.18","ind":"-0.25"},{"date":"2026.03.27","stock":"1.20","trade":"2.53","ind":"1.13"},{"date":"2026.03.26","stock":"-0.83","trade":"-0.80","ind":"-1.41"},{"date":"2026.03.25","stock":"3.79","trade":"1.38","ind":"1.95"},{"date":"2026.03.24","stock":"5.51","trade":"3.44","ind":"1.43"},{"date":"2026.03.23","stock":"-6.31","trade":"-5.85","ind":"-3.76"},{"date":"2026.03.20","stock":"-3.37","trade":"-1.99","ind":"-0.25"},{"date":"2026.03.19","stock":"-3.56","trade":"-1.92","ind":"-2.02"},{"date":"2026.03.18","stock":"1.33","trade":"0.39","ind":"1.05"},{"date":"2026.03.17","stock":"-2.93","trade":"-0.68","ind":"-1.87"},{"date":"2026.03.16","stock":"-0.34","trade":"0.40","ind":"0.19"}]

维康药业,深证成指,中药指数

压力支撑

该股压力位为26.50元，支撑位为25.84元。

[{"text":"\u538b\u529b\u4f4d","value":"26.50","date":1776096000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"25.84","date":1776096000,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.6资金面打败了76%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：04月14日 17:30

机构今日流向(万元)	-1370.07	机构5日流向(万元)	-8920.48
机构10日流向(万元)	-8577.50	机构20日流向(万元)	-11283.68

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1042.31万股，其中基金净减仓1家，主力净减仓3家，请投资者中长期谨慎为宜。

截止2025-12-31，共4家主力机构（基金4家），持仓量总计1.21万股，占流通A股0.01%
其中，基金持仓与2025-06-30相比：
增仓：0家，增持 0万股
减仓：1家，减持 1.02万股
新出现在主力名单中：3家，持有0.41万股
从主力名单中消失：6家，原持有1041.7万股

消息面诊股

诊断结果：4.9消息面打败了9%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	公司股东股份解押	2026-03-18
一般消息	高管变动	聘任为公司董事会秘书	2026-02-05
重大利空	业绩预告	预计增亏	2026-01-26
一般消息	高管变动	因公司治理结构调整	2025-12-10
一般消息	股东大会	临时股东大会	2025-11-25
利空	重大事项	公司违规：处罚类型	2025-10-21
一般消息	分红转增	不分配不转增	2025-08-28
一般消息	高管变动	因个人原因	2025-08-08
利空	重大事项	公司违规：处罚类型	2025-07-11
利好	分红转增	10派1.4元(含税)	2025-04-29
一般消息	重大事项	关联交易	2025-04-29

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	3条	1条	2条

行业面诊股

诊断结果：2.4行业面打败了17%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.04.14","price":"1.61","value":"0.36"},{"date":"2026.04.13","price":"0.69","value":"-1.82"},{"date":"2026.04.10","price":"2.24","value":"0.01"},{"date":"2026.04.09","price":"-0.33","value":"-1.54"},{"date":"2026.04.08","price":"4.79","value":"0.62"},{"date":"2026.04.07","price":"0.36","value":"0.87"},{"date":"2026.04.03","price":"-0.99","value":"-2.39"},{"date":"2026.04.02","price":"-1.60","value":"0.62"},{"date":"2026.04.01","price":"1.70","value":"2.36"},{"date":"2026.03.31","price":"-1.81","value":"-0.69"},{"date":"2026.03.30","price":"-0.25","value":"1.18"},{"date":"2026.03.27","price":"1.13","value":"2.53"},{"date":"2026.03.26","price":"-1.41","value":"-0.80"},{"date":"2026.03.25","price":"1.95","value":"1.38"},{"date":"2026.03.24","price":"1.43","value":"3.44"},{"date":"2026.03.23","price":"-3.76","value":"-5.85"},{"date":"2026.03.20","price":"-0.25","value":"-1.99"},{"date":"2026.03.19","price":"-2.02","value":"-1.92"},{"date":"2026.03.18","price":"1.05","value":"0.39"},{"date":"2026.03.17","price":"-1.87","value":"-0.68"},{"date":"2026.03.16","price":"0.19","value":"0.40"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万邦德	62.64%	-20.83%	5.8分
2	沃华医药	15.49%	8.75%	6.2分
3	益佰制药	8.25%	-13.57%	4.6分
4	健民集团	5.20%	-2.30%	5.5分
5	东阿阿胶	4.89%	-1.05%	5.8分
6	九芝堂	4.40%	-1.15%	5.4分
7	华润江中	3.06%	-0.35%	6.1分
8	ST葫芦娃	2.34%	6.07%	5.4分
9	ST香雪	1.59%	-2.04%	5.1分
10	振东制药	1.33%	-3.49%	4.8分
11	众生药业	0.60%	-1.60%	5.2分
12	桂林三金	0.43%	-0.91%	5.8分
13	广誉远	0.17%	-1.49%	5.2分
14	康惠股份	-0.07%	7.56%	6.0分
15	华森制药	-0.14%	-2.69%	5.3分
16	吉林敖东	-1.13%	4.56%	5.6分
17	羚锐制药	-1.33%	-2.28%	5.2分
18	仁和药业	-1.69%	-0.34%	5.2分
19	康恩贝	-1.80%	-1.13%	5.4分
20	红日药业	-1.93%	-3.01%	5.3分
21	ST百灵	-1.96%	0.40%	4.8分
22	精华制药	-2.08%	-2.59%	5.9分
23	亚宝药业	-2.24%	-3.96%	5.7分
24	天士力	-2.38%	-0.78%	5.3分
25	葵花药业	-2.63%	-1.53%	4.3分
26	以岭药业	-2.65%	-1.25%	5.6分
27	特一药业	-2.86%	-2.68%	5.7分
28	粤万年青	-3.00%	0.00%	4.9分
29	云南白药	-3.06%	-1.54%	6.4分
30	太龙药业	-3.20%	-1.22%	5.1分
31	达仁堂	-3.20%	0.25%	5.2分
32	太极集团	-3.32%	-2.45%	4.9分
33	马应龙	-3.34%	-0.79%	5.5分
34	嘉应制药	-3.50%	1.85%	4.9分
35	陇神戎发	-3.57%	-1.15%	5.7分
36	金花股份	-3.81%	-3.36%	4.8分
37	奇正藏药	-4.46%	-0.30%	5.6分
38	千金药业	-4.46%	-1.87%	6.2分
39	佛慈制药	-4.69%	-3.94%	5.2分
40	信邦制药	-4.71%	-3.28%	5.2分
41	步长制药	-4.71%	-2.47%	5.5分
42	中恒集团	-4.92%	-4.56%	4.9分
43	佐力药业	-5.30%	1.30%	5.4分
44	华神科技	-5.45%	-6.56%	5.3分
45	汉森制药	-5.58%	-4.35%	5.4分
46	新天药业	-5.66%	-17.31%	5.0分
47	盘龙药业	-5.67%	-5.11%	4.6分
48	三力制药	-5.98%	-2.05%	5.8分
49	康缘药业	-6.04%	-1.72%	5.1分
50	济川药业	-6.31%	-3.94%	5.2分
51	康美药业	-6.42%	-1.13%	5.1分
52	古汉医药	-6.44%	-2.41%	5.3分
53	华润三九	-6.48%	-1.69%	5.8分
54	寿仙谷	-6.57%	-1.11%	5.1分
55	恩威医药	-6.84%	-0.83%	6.1分
56	上海凯宝	-6.92%	-1.17%	5.4分
57	同仁堂	-7.03%	1.70%	5.5分
58	新光药业	-7.57%	-2.26%	5.1分
59	天目药业	-7.57%	-7.09%	5.1分
60	益盛药业	-7.71%	-5.01%	5.3分
61	片仔癀	-7.80%	-1.35%	4.8分
62	昆药集团	-8.23%	-1.85%	4.8分
63	珍宝岛	-8.91%	0.88%	4.8分
64	-	-8.97%	1.52%	分
65	维康药业	-9.73%	-4.43%	4.5分
66	-	-10.21%	-0.97%	分
67	白云山	-10.56%	0.44%	5.6分
68	方盛制药	-12.02%	-2.84%	5.5分

<上一页 1 2 3 4 5...12 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.1基本面打败了1%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（77.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 64/107 ， 66/107。

[{"date":"2025-09-30","value":"-11.41","vol":"4.81"},{"date":"2025-06-30","value":"-5.76","vol":"4.04"},{"date":"2025-03-31","value":"-0.85","vol":"2.25"},{"date":"2024-12-31","value":"-11.57","vol":"4.87"},{"date":"2024-09-30","value":"3.22","vol":"5.62"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	-11.41	-5.76	-0.85	-11.57	3.22
行业(%)	4.81	4.04	2.25	4.87	5.62

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"15.34","vol":"53.26"},{"date":"2025-06-30","value":"21.77","vol":"53.79"},{"date":"2025-03-31","value":"51.40","vol":"54.43"},{"date":"2024-12-31","value":"38.18","vol":"53.69"},{"date":"2024-09-30","value":"47.39","vol":"53.56"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	15.34	21.77	51.40	38.18	47.39
行业(%)	53.26	53.79	54.43	53.69	53.56

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 66/107 ， 65/107。

[{"date":"2025-09-30","value":"-59.20","vol":"-7.81"},{"date":"2025-06-30","value":"-61.42","vol":"-7.74"},{"date":"2025-03-31","value":"-65.10","vol":"-7.31"},{"date":"2024-12-31","value":"-32.41","vol":"-6.13"},{"date":"2024-09-30","value":"-14.16","vol":"-3.58"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-59.20	-61.42	-65.10	-32.41	-14.16
行业(%)	-7.81	-7.74	-7.31	-6.13	-3.58

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-380.87","vol":"-2.50"},{"date":"2025-06-30","value":"-552.50","vol":"2.58"},{"date":"2025-03-31","value":"-140.50","vol":"-37.35"},{"date":"2024-12-31","value":"-1546.42","vol":"-148.45"},{"date":"2024-09-30","value":"-36.41","vol":"65.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-380.87	-552.50	-140.50	-1546.42	-36.41
行业(%)	-2.50	2.58	-37.35	-148.45	65.47

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 64/107 ， 41/107。

[{"date":"2025-09-30","value":"0.10","vol":"0.35"},{"date":"2025-06-30","value":"0.07","vol":"0.24"},{"date":"2025-03-31","value":"0.04","vol":"0.13"},{"date":"2024-12-31","value":"0.19","vol":"0.50"},{"date":"2024-09-30","value":"0.19","vol":"0.38"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.10	0.07	0.04	0.19	0.19
行业(次)	0.35	0.24	0.13	0.50	0.38

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.27","vol":"1.72"},{"date":"2025-06-30","value":"0.79","vol":"1.17"},{"date":"2025-03-31","value":"0.27","vol":"0.60"},{"date":"2024-12-31","value":"1.60","vol":"2.41"},{"date":"2024-09-30","value":"1.48","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.27	0.79	0.27	1.60	1.48
行业(次)	1.72	1.17	0.60	2.41	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-3.87","vol":"10.53"},{"date":"2025-06-30","value":"113.62","vol":"22.82"},{"date":"2025-03-31","value":"-9.30","vol":"2.07"},{"date":"2024-12-31","value":"","vol":"22.07"},{"date":"2024-09-30","value":"-20.77","vol":"6.09"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-3.87	113.62	-9.30	-	-20.77
行业	10.53	22.82	2.07	22.07	6.09

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.74","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.82","vol":"1.48"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.74	-	1.82	-
行业	0.00	1.03	0.00	1.48	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 16/107 ， 38/107。

[{"date":"2025-09-30","value":"2.34","vol":"3.09"},{"date":"2025-06-30","value":"2.56","vol":"2.94"},{"date":"2025-03-31","value":"2.68","vol":"3.03"},{"date":"2024-12-31","value":"2.56","vol":"2.92"},{"date":"2024-09-30","value":"5.16","vol":"3.30"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.34	2.56	2.68	2.56	5.16
行业	3.09	2.94	3.03	2.92	3.30

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.84","vol":"2.24"},{"date":"2025-06-30","value":"1.94","vol":"2.15"},{"date":"2025-03-31","value":"1.96","vol":"2.24"},{"date":"2024-12-31","value":"1.96","vol":"2.13"},{"date":"2024-09-30","value":"4.27","vol":"2.46"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.84	1.94	1.96	1.96	4.27
行业	2.24	2.15	2.24	2.13	2.46

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 26/107 ， 30/107。

[{"date":"2025-09-30","value":"30.80","vol":"31.59"},{"date":"2025-06-30","value":"29.55","vol":"32.44"},{"date":"2025-03-31","value":"28.99","vol":"31.90"},{"date":"2024-12-31","value":"28.96","vol":"32.73"},{"date":"2024-09-30","value":"25.67","vol":"32.27"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	30.80	29.55	28.99	28.96	25.67
行业(%)	31.59	32.44	31.90	32.73	32.27

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.45","vol":"0.76"},{"date":"2025-06-30","value":"0.43","vol":"0.75"},{"date":"2025-03-31","value":"0.41","vol":"0.74"},{"date":"2024-12-31","value":"0.41","vol":"0.76"},{"date":"2024-09-30","value":"0.35","vol":"0.73"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.45	0.43	0.41	0.41	0.35
行业(%)	0.76	0.75	0.74	0.76	0.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"0.96","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.49","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.09","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.47","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[维康药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]